Literature DB >> 28708135

Regulation of PLK1 through competition between hnRNPK, miR-149-3p and miR-193b-5p.

Chang Hoon Shin1, Hong Lee1, Hye Ree Kim1, Kyung Hee Choi1, Je-Gun Joung2, Hyeon Ho Kim1,3.   

Abstract

Polo-like kinase 1 (PLK1) is a critical regulator of cell cycle progression and apoptosis. However, its regulation remains poorly understood. In the present study, we investigated the molecular mechanism underlying the post-transcriptional regulation of PLK1. We observed that heterogeneous nuclear ribonucleoprotein K (hnRNPK) and PLK1 were positively associated in several different cancers and high expression levels of them correlated with poor prognosis in patients with cancer. Knockdown of hnRNPK resulted in reduced expression of PLK1, whereas conversely, PLK1 expression was increased in hnRNPK-overexpressing cells. We found that hnRNPK regulated PLK1 expression through KH1- and KH2-dependent interactions with the 3'UTR of PLK1 mRNA. In addition, microRNA-149-3p (miR-149-3p) and miR-193b-5p suppressed PLK1 expression by targeting the 3'UTR of PLK1 mRNA. MicroRNA-elicited enrichment of PLK1 mRNA in Ago2 immunoprecipitation was altered by the presence or absence of hnRNPK. Furthermore, the deletion of the cytosine (C)-rich sequences of the 3'UTR of PLK1 mRNA abolished the decreased PLK1 expression observed via hnRNPK silencing and administration of miRNAs, a finding that suggests that hnRNPK shares this C-rich motif with miR-149-3p and miR-193b-5p. We also found that downregulation of PLK1 by either silencing hnRNPK or overexpression of miR-149-3p and miR-193b-5p decreased clonogenicity and induced apoptosis. Our findings from this study demonstrate that hnRNPK regulates PLK1 expression by competing with the PLK1-targeting miRNAs, miR-149-3p and miR-193b-5p.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28708135      PMCID: PMC5635212          DOI: 10.1038/cdd.2017.106

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  53 in total

Review 1.  Post-transcriptional regulation in cancer.

Authors:  Yann Audic; Rebecca S Hartley
Journal:  Biol Cell       Date:  2004-09       Impact factor: 4.458

2.  Multiple and specific mRNA processing targets for the major human hnRNP proteins.

Authors:  Julian P Venables; Chu-Shin Koh; Ulrike Froehlich; Elvy Lapointe; Sonia Couture; Lyna Inkel; Anne Bramard; Eric R Paquet; Valérie Watier; Mathieu Durand; Jean-François Lucier; Julien Gervais-Bird; Karine Tremblay; Panagiotis Prinos; Roscoe Klinck; Sherif Abou Elela; Benoit Chabot
Journal:  Mol Cell Biol       Date:  2008-07-21       Impact factor: 4.272

3.  Heterogeneous nuclear ribonucleoprotein K is overexpressed and associated with poor prognosis in gastric cancer.

Authors:  Ruirui Yang; Ying Zeng; Haifan Xu; Zhuo Chen; Mengqin Xiang; Yun Fu; Yufang Yin; Jing Zhong; Min Zeng; Peihua Wang; Qin You; Xi Zeng
Journal:  Oncol Rep       Date:  2016-06-02       Impact factor: 3.906

Review 4.  Polo-like kinases: a team that plays throughout mitosis.

Authors:  D M Glover; I M Hagan; A A Tavares
Journal:  Genes Dev       Date:  1998-12-15       Impact factor: 11.361

5.  The K nuclear shuttling domain: a novel signal for nuclear import and nuclear export in the hnRNP K protein.

Authors:  W M Michael; P S Eder; G Dreyfuss
Journal:  EMBO J       Date:  1997-06-16       Impact factor: 11.598

6.  Immunohistochemical detection of HSP27 and hnRNP K as prognostic and predictive biomarkers for colorectal cancer.

Authors:  Feng Wang; Peng Zhang; Chenzhang Shi; Yongzhi Yang; Huanlong Qin
Journal:  Med Oncol       Date:  2011-08-23       Impact factor: 3.064

7.  Involvement of Hu and heterogeneous nuclear ribonucleoprotein K in neuronal differentiation through p21 mRNA post-transcriptional regulation.

Authors:  Masato Yano; Hirotaka J Okano; Hideyuki Okano
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

8.  The pre-mRNA binding K protein contains a novel evolutionarily conserved motif.

Authors:  H Siomi; M J Matunis; W M Michael; G Dreyfuss
Journal:  Nucleic Acids Res       Date:  1993-03-11       Impact factor: 16.971

9.  Expression of polo-like kinase (PLK1) in thin melanomas: a novel marker of metastatic disease.

Authors:  Lucas Kneisel; Klaus Strebhardt; August Bernd; Manfred Wolter; Angelika Binder; Roland Kaufmann
Journal:  J Cutan Pathol       Date:  2002-07       Impact factor: 1.587

10.  Cloning and characterization of human and murine homologues of the Drosophila polo serine-threonine kinase.

Authors:  R Hamanaka; S Maloid; M R Smith; C D O'Connell; D L Longo; D K Ferris
Journal:  Cell Growth Differ       Date:  1994-03
View more
  17 in total

1.  Human placental microRNAs dysregulated by cadmium exposure predict neurobehavioral outcomes at birth.

Authors:  Jesse M Tehrani; Elizabeth Kennedy; Pei Wen Tung; Amber Burt; Karen Hermetz; Tracy Punshon; Brian P Jackson; Ke Hao; Jia Chen; Margaret R Karagas; Devin C Koestler; Barry Lester; Carmen J Marsit
Journal:  Pediatr Res       Date:  2022-07-29       Impact factor: 3.953

2.  Potential pathophysiological role of microRNA 193b-5p in human placentae from pregnancies complicated by preeclampsia and intrauterine growth restriction.

Authors:  Zain Awamleh; Victor K M Han
Journal:  Mol Biol Rep       Date:  2020-08-16       Impact factor: 2.316

3.  Circular RNA Expression Profiles and the Pro-tumorigenic Function of CircRNA_10156 in Hepatitis B Virus-Related Liver Cancer.

Authors:  Man Wang; Bianli Gu; Guoliang Yao; Peifeng Li; Kun Wang
Journal:  Int J Med Sci       Date:  2020-05-30       Impact factor: 3.738

Review 4.  Post-translational modification control of RNA-binding protein hnRNPK function.

Authors:  Yongjie Xu; Wei Wu; Qiu Han; Yaling Wang; Cencen Li; Pengpeng Zhang; Haixia Xu
Journal:  Open Biol       Date:  2019-03-29       Impact factor: 6.411

5.  Dual-strand tumor suppressor miR-193b-3p and -5p inhibit malignant phenotypes of lung cancer by suppressing their common targets.

Authors:  Kyung Hee Choi; Chang Hoon Shin; Woo Joo Lee; Haein Ji; Hyeon Ho Kim
Journal:  Biosci Rep       Date:  2019-07-12       Impact factor: 3.840

6.  Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation.

Authors:  Hengqing Zhu; Qing Li; Yulan Zhao; Hong Peng; Liangyun Guo; Jing Zhu; Zi Jiang; Zhaoxia Zeng; Bin Xu; Sisi Chen
Journal:  Oncogene       Date:  2021-06-17       Impact factor: 9.867

Review 7.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

8.  Cadmium Nephrotoxicity Is Associated with Altered MicroRNA Expression in the Rat Renal Cortex.

Authors:  Michael J Fay; Lauren A C Alt; Dominika Ryba; Ribhi Salamah; Ryan Peach; Alexander Papaeliou; Sabina Zawadzka; Andrew Weiss; Nil Patel; Asad Rahman; Zyaria Stubbs-Russell; Peter C Lamar; Joshua R Edwards; Walter C Prozialeck
Journal:  Toxics       Date:  2018-03-15

9.  HRPK-1, a conserved KH-domain protein, modulates microRNA activity during Caenorhabditis elegans development.

Authors:  Li Li; Isana Veksler-Lublinsky; Anna Zinovyeva
Journal:  PLoS Genet       Date:  2019-10-04       Impact factor: 5.917

10.  CD44v6 Targeted by miR-193b-5p in the Coding Region Modulates the Migration and Invasion of Breast Cancer Cells.

Authors:  Song Hu; Manlin Cao; Yiqing He; Guoliang Zhang; Yiwen Liu; Yan Du; Cuixia Yang; Feng Gao
Journal:  J Cancer       Date:  2020-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.